Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Tele-CF: A Practical Platform for Remote Monitoring of Cognitive Frailty
Authors not listed
Baylor College of Medicine · 2022
Abstract
Cognitive frailty, characterized by the coexistence of physical frailty and cognitive impairment, is a robust indicator of cognitive decline. Recognizing its significance, the International Association of Gerontology and Geriatrics and the International Academy on Nutrition and Aging have advocated for the use of cognitive frailty assessment as a means of monitoring the progression of mild cognitive impairment towards debilitating conditions like dementia, Alzheimer's disease, and loss of independence. Despite the clear need, a practical and remotely accessible tool for measuring cognitive frailty is currently lacking, especially within the context of telehealth visits. With telehealth video-conferencing becoming increasingly popular, accepted by healthcare payers, and preferred by older adults who may face difficulties traveling to a clinic, there is a pressing need for a software-based solution for remote cognitive frailty assessment that can be easily integrated into existing telehealth systems. This study proposes designing and validating a video-based solution to remotely monitor cognitive-frailty in older adults.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2022). Tele-CF: A Practical Platform for Remote Monitoring of Cognitive Frailty. <em>Baylor College of Medicine</em>. https://clinicaltrials.gov/study/NCT05754021
Vancouver
Anonymous. Tele-CF: A Practical Platform for Remote Monitoring of Cognitive Frailty. Baylor College of Medicine. 2022.
BibTeX
@misc{anon2022TeleCF,
title = {Tele-CF: A Practical Platform for Remote Monitoring of Cognitive Frailty},
author = {Anonymous},
journal = {Baylor College of Medicine},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biomed Industries, Inc. 2018
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Efficacy of NA-831 in Alzheimer Patients With Mild Cognitive Impairment
Ali Rezai, MD 2012
Open access · US-GOV
Deep Brain Stimulation (DBS) for Treatment of the Cognitive, Behavioral, and Functional Disability of Alzheimer's Disease
University of California, San Francisco 2021
Open access · US-GOV
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
New York State Psychiatric Institute 2010
Open access · US-GOV
BAY 94-9172 PET/CT in Cognitively Normal Older Adults, Older Adults With Mild Cognitive Impairment, and Older Adults With Alzheimer's Disease
Avraham Pharmaceuticals Ltd 2012
Open access · US-GOV
A 36-month, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment (MCI)
Pennington Biomedical Research Center 2021
Open access · US-GOV